Haematopoietic stem cells (HSCs) capable of long-term multilineage reconstitution in myeloablated recipient mice first arise during embryogenesis and persist into adult life. The differentiation pathways and cytokine requirements through which haematopoietic progenitor cells achieve maturity in all blood cell lineages have been studied extensively and are well characterized. However, the processes by which the stem cells and precursors that seed the adult multilineage blood system are generated and maintained are less well understood. Stem cell homeostasis depends on maintaining a balance between self-renewal, proliferation, death and differentiation. Identification of the factors that regulate HSC emergence and subsequent development will provide insight into how the mammalian haematopoietic system is formed and how the decision to self-renew or differentiate is controlled at the molecular level.
Summary
The transforming growth factor-b-related factor bone morphogenetic protein 4 (BMP4) is expressed in the human embryonic aorta-gonad-mesonephros (AGM) coincident with the emergence of haematopoietic cells and influences postnatal mammalian haematopoietic stem cells in vitro. Progenitors that display haemangioblast (haematopoietic and endothelial) potential in vitro, similar to embryonic stem (ES) cell lines, have been identified early in the development of the gastrulating mouse embryo (Choi et al, 1998; Huber et al, 2004) . The proximity of intraaortic HSCs to endothelial cells lining the dorsal aorta, combined with the overlapping expression profiles between the two populations, suggest that HSCs and endothelial cells arise from a bipotential precursor, the haemangioblast, located within or adjacent to the aortic wall (Marshall & Thrasher, 2001) . In support of this, CD34 + / CD45 ) endothelial cells isolated from 5-week human AGM lack haematopoietic potential initially but produce blood cells when cultured in the presence of stromal cells that support multilineage haematopoiesis (Oberlin et al, 2002) . Haematopoietic output from endothelial cells both quantitatively and temporally reflects the degree of haematopoietic activity in vivo and is restricted to blood-forming tissues.
A number of extrinsic factors have been reported to influence haematopoiesis including members of the hedgehog, Wnt, Notch and transforming growth factor-b (TGFb)/bone morphogenetic protein (BMP) families (Fortunel et al, 2000; Bhardwaj et al, 2001; Kumano et al, 2003; Reya et al, 2003; Sadlon et al, 2004; Androutsellis-Theotokis et al, 2006; Neves et al, 2006) . BMPs have a broad spectrum of effects during embryogenesis, ranging from induction of ventral mesoderm to patterning a variety of tissues (Winnier et al, 1995; Hogan, 1996) . During lower vertebrate (Xenopus) embryogenesis the genetic programming of putative haemangioblasts is regulated by bone morphogenetic protein 4 (BMP4) (Walmsley et al, 2002) . BMPs also enhance self-renewal and increase the haematopoietic potential of ES cells (Johansson & Wiles, 1995; Chadwick et al, 2003; Chambers & Smith, 2004) . Recently, BMP signalling has been implicated in adult murine bone marrow homeostasis in the regulation of niche size and stem cell numbers (Zhang et al, 2003) . In vitro, while BMP4 maintains the proliferative potential of cord blood-derived CD34 + haematopoietic progenitors, TGFb regulates cell cycle status and expression of the stem cell factor receptor c-Kit to maintain a primitive, undifferentiated population (Sansilvestri et al, 1995; Bhatia et al, 1999; Morita et al, 2003) . We have previously shown that BMP4 is expressed in a distinctive pattern underlying the ventral wall of the dorsal aorta associated with the appearance of intraaortic haematopoietic clusters in the AGM region of 5-week old human embryos (Marshall et al, 2000) . To investigate the role of BMP4 at the onset of multipotent haematopoietic development during mammalian embryogenesis, we have isolated cells co-expressing CD34 and c-Kit from the AGM region of midgestation murine embryos (9AE5-11AE5 dpc), at the time of normal HSC emergence. This CD34 + /c-Kit+ population has previously been shown to give rise to cells of all haematopoietic lineages in vitro indicating that it contains multipotent HSCs (Delassus et al, 1999) . Coincident with the peak of AGM haematopoietic activity in vivo, we have identified two populations of CD34 + AGM cells that differ in c-Kit expression and differentiation potential. BMP4, specifically, modulates the size and potential of these populations ex vivo, similar to the effects of TGFb in the adult blood system. This effect can be neutralized by inhibition of BMP signalling using antagonists. These findings, together with the observed in vivo expression pattern, support a role for BMP4 in the development and regulation of early haematopoietic progenitors within the mammalian embryonic AGM region.
Methods

AGM dissection and cell preparation
Timed matings of wild-type CD1 mice generated embryos at embryonic day (9AE5, 10AE5 and 11AE5). From each embryo, the AGM region between the anterior limb bud and umbilical vessels, containing the dorsal aorta, was dissected in phosphate-buffered saline (PBS). AGMs from single litters were pooled and dissociated in cell dissociation buffer (Invitrogen Ltd, Paisley, UK) for 15 min at 37°C followed by gentle trituration through 23 and 25 G needles. Single cells were filtered through a 70 lm cell strainer and washed with Hank's balanced salt solution (HBSS) supplemented with 1% bovine serum albumin (BSA).
Flow cytometry and fluorescence-activated cell sorting 
Microscopy
Colonies/cells were analysed using a Nikon Eclipse TS100 inverted microscope (Nikon Corporation, Tokyo, Japan) with a 20·/0AE40 objective for bright field. Images were captured with a Nikon Coolpix 4500 digital camera and processed using Adobe Photoshop 5AE5 (Adobe systems, San Jose, CA, USA).
Results
Mid-gestation murine CD34 + AGM cells generate morphologically different colonies depending on level of c-Kit expression Flow cytometric analysis of cells isolated from mid-gestation murine embryos (pooled 10AE5 dpc littermates) suggested that the AGM contained two subpopulations of CD34 + cells that differentially expressed c-Kit ( Fig 1A) . These two subpopulations were also analysed for expression of the vascular endothelial growth factor receptor Flk1 and the pan-leucocyte marker CD45. 
We investigated the effect of BMP4 on c-Kit expression levels in AGM-derived murine cells. Unsorted AGM cells (10AE5 dpc) were cultured on a low-density monolayer of irradiated S17 stromal cells in serum-free medium alone or medium supplemented with recombinant BMP4 (10 ng/ml). Cells were collected at day 2 and analysed by flow cytometry for CD34 and c-Kit expression compared to the starting population. In a representative experiment, CD34
+ /c-Kit BMP4 increases the growth/survival of AGM-derived CD34 + /c-kit high cells in vitro
Modulation of c-Kit expression may be one mechanism by which the balance between blood cell precursors and progenitors is maintained during AGM haematopoiesis. We therefore investigated the longer term effects of BMP4 on AGM-derived CD34 + /c-Kit high cells isolated by FACS from embryos aged between 9AE5 and 11AE5 dpc and cultured as above on irradiated S17 stromal cells in serum-free conditions with or without BMP4 (10 ng/ml) for 10 d. At the end of the culture period, the number of AGM-derived colonies generated under each condition (plating efficiency) was scored. (Fig 2A) . In contrast, the number of colonies generated from BMP4-treated 10AE5 dpc CD34 + /c-Kit high cells increased significantly (P < 0AE001) and reproducibly with a greater than twofold increase in 14 out of 19 independent experiments, some reaching as high as 16 times control levels ( Fig 2B) . Addition of c-Kit ligand (25 ng/ml), either alone or in combination with BMP4, had no observable effect on colony number, size or morphology.
The effects of BMP4 are neutralized by BMP-antagonists
To test whether the observed increase in colony formation from 10AE5 dpc AGM-derived CD34 + /c-kit high cells was BMP-specific, the high-affinity BMP-binding protein noggin and recombinant soluble BMP type I-receptor (BMPR-IB) were added in combination with BMP4 to block BMP signalling in culture. Noggin is one of a number of antagonistic agents that regulate BMP bioactivity during embryonic development by sequestering BMP molecules in the extracellular space. Recombinant BMPR acts in a similar way in vitro, binding BMP4 with high affinity in solution. After 10 d in culture with BMPR or noggin (200 ng/ml) the number of colonies generated fell to control levels or less (Fig 2C and D) . The inhibitors were not toxic at the concentrations used and the number, size and morphology of colonies were comparable to untreated controls ()BMP4). In one experiment ( Fig 2D,  experiment 2 ), although BMP4 alone had no significant effect, addition of noggin reduced the number of colonies formed. However, this result was not typical and in other experiments noggin had a similar effect to BMP-R. The level of c-Kit expression was an indicator of the differentiation potential of 10AE5 dpc CD34 + AGM cells (Fig 1B) . In methylcellulose assays, isolated CD34 + /c-Kit high cells generated haematopoietic colonies typical of committed progenitors. To assess the effect of BMP4 on the colonyforming potential of committed progenitors, colonies generated in 10-or 20-d cultures from FACS-isolated results in an increase in the number of colonies produced at 10AE5 dpc compared with serum-free conditions ()BMP4, solid symbols). Statistical analyses were performed using the Kruskal-Wallis test (different embryonic ages) and the non-parametric Wilcoxon signed rank test to compare the collective results for a given embryonic age with and without addition of BMP4. Results were found to be significant at 10AE5 dpc (P < 0AE001) but not significant at 9AE5 dpc or 11AE5 dpc (P ¼ 0AE068 and P ¼ 0AE595 respectively). (B) The effect of BMP4 was consistent at 10AE5 dpc, increasing plating efficiency/CFUs by 50% or greater in 12 out of 19 separate experiments. BMP inhibitors. (C) soluble BMP type I-receptor (200 ng/ml) and (D) Noggin (200 ng/ml) neutralize the effect of BMP4 on cultured CD34 + /c-Kit high cells (10AE5 dpc). (Table I , Fig 3A) , suggesting that lineage-restricted haematopoietic progenitors (CFU-GM) were maintained or generated within the cultures. BMP4-treated CD34 + /c-Kit high cells also generated colonies that contained erythroid cells, indicating the presence of more primitive, less restricted progenitors (CFU-GEMM) (Fig 3B) . Most strikingly, CD34 + /c-kit high cells at all embryonic ages pre-cultured with BMP4 generated adherent colonies that closely resembled the colonies produced from CD34 + /c-Kit low cells at day 0 (Table I , Fig 3C) . These colonies contained a mixture of adherent spindle-shaped and large round cells overlaid by clusters of smaller round cells and frequently formed extensive networks that persisted in culture for more than 4 weeks. Immunocytochemical analysis of adherent colonies showed expression of the stromal molecule STRO1 in large round cells, endothelial (Flk1, endoglin) markers in large round and spindle cells and the haematopoietic marker CD45 in small round cells. Adherent colonies therefore appeared to comprise a combination of stromal, endothelial and haematopoietic cells. In most cultures, both non-adherent haematopoietic and adherent colonies were generated, however, a number of cultures produced adherent colonies exclusively. This adherent colony-forming potential was retained by cells isolated at 10AE5 dpc but lost on extended culture of 11AE5 dpc cells. Importantly, no adherent colonies were generated from CD34 + /c-kit high cultured in the absence of exogenous BMP4. The colony-forming potential of AGM-derived CD34 + /c-Kit high cells (10AE5 dpc) that had been + /c-Kit high cells also produce (B) haematopoietic colonies which also contain erythroid cells (CFU-GEMM) and (C) at a similar frequency, adherent colonies which resemble colonies generated from freshly isolated CD34 + /c-Kit low cells of the same embryonic age. Adherent colonies contain three morphologically distinct cell types: phase-dim spindle-shaped cells (arrowhead), large round cells (arrow) and phase-bright small, round cells (hatched arrow).
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pre-cultured with soluble BMP-receptor or noggin in combination with BMP4 was also assessed (Table II ). The addition of noggin prevented polymorphic colony formation although some hematopoietic (CFU-GM) colonies did develop. Soluble BMP-receptor completely blocked colony formation.
Discussion
Stem cells play an essential role in the generation (embryonic/ foetal) and regeneration (adult) of tissues. To fulfil these roles, stem cells must survive and persist within tissues and also be able to generate specialized, differentiated progeny as required. Maintenance of the stem cell pool therefore requires a precise balance between a number of processes: self-renewal (quiescence), proliferation, differentiation and apoptosis. These processes are regulated by a complex network of environmental (niche) signals linked to intrinsic pathways that can have either a permissive or an inhibitory effect on stem cell behaviour. BMP is an example of an extracellular molecule that functions in this way, with distinct or overlapping functions that induce or inhibit, depending on the stem cell system and specificity of receptor binding (Zhang & Li, 2005) .
The mammalian AGM region contains a niche in which haematopoietic stem cells are generated from a pre-haematopoietic cell during embryogenesis and BMP4 is expressed during this period of HSC emergence in vivo in human embryos (Marshall et al, 2000) . The AGM is possibly the only intraembryonic site of multipotent HSC specification during development, with subsequent foetal liver and bone marrow haematopoiesis seeded by the self-renewal and proliferation of AGM-derived cells rather than the de novo generation of HSCs in these tissues. The AGM therefore provides an important and possibly unique environment for the study of early haematopoietic ontogeny in terms of cellular origin and molecular regulation.
The most primitive haematopoietic progenitors in human bone marrow express the stem cell factor receptor c-Kit at low levels compared to more committed progenitors (Gunji et al, 1993; Katayama et al, 1993; Doi et al, 1997; Lian et al, 1997) . This study showed that c-Kit expression in murine embryonic CD34 + AGM cells also distinguishes two subpopulations that differ in colony-forming potential. The c-Kit high compartment expressed the pan-leucocyte marker CD45 and contained lineage-restricted haematopoietic progenitors (CFU-GM). In contrast, the CD34 + /c-Kit low subpopulation was CD45-negative and did not contain CFU-GM but generated adherent colonies containing multiple cell types. CD34 + /c-Kit low AGM cells also express the vascular endothelial growth factor (VEGF) receptor Flk1. Flk1 is expressed on cell blast-colony forming cells (BL-CFCs) derived from murine ES cells in culture (Faloon et al, 2000) . These BL-CFCs display both endothelial and haematopoietic potential and are thought to represent the in vitro equivalent of the haemangioblast (Choi et al, 1998 multiple cell types and could persist and expand in culture for several weeks. Preliminary analysis of these colonies suggested that they contained a mixture of cells that express stromal, endothelial or haematopoietic markers (data not shown). They also morphologically resembled haemangioblast colonies obtained from human embryonic stem cells cultured with BMP4 . In the presence of BMP4, therefore, CD34/c-Kit AGM cells underwent a change in differentiation potential coincident with a change in c-Kit expression. This concurs with the in vivo expression pattern of c-Kit within the embryonic AGM. In the human embryo, KIT mRNA is expressed at higher levels in cells within intraaortic CD45 + haematopoietic clusters compared to the surrounding vasculature (Labastie et al, 1998) . AGM-derived c-Kit high cells may therefore correspond to cells within intraaortic haematopoietic clusters in the mid-gestation murine AGM. Similarly, in vivo CD34 expression patterns in mouse and human embryos suggest that CD34 + /c-Kit low cells are located within the vascular walls including the dorsal aorta (Tavian et al, 1996; Wood et al, 1997) . CD34 + /c-Kit low cells Based on these results, we propose a model for mammalian embryonic haematopoietic development that requires BMP signalling at an early stage for maintenance of multipotent cells in the AGM. BMP4 maintains and possibly activates progenitors or stem cells within the ventral floor of the endothelium lining the dorsal aorta. At this point, these cells have the potential to self-renew or to differentiate along one of at least two lineage pathways. In response to BMP4 and/or other factors within the AGM niche, these progenitors proliferate and are pushed outwards from the vessel wall to form clusters in the lumen. These clusters are continuous with and connected to the vessel wall by cell-cell junctions (Marshall & Thrasher, 2001) . As cells within the developing clusters move away from the aortic wall and the source of BMP, they lose multipotency and become committed to a haematopoietic fate. Exposure of lineage-committed progenitors to BMP4 in vitro restores a more primitive phenotype, suggesting that BMP4 maintains precursors or HSCs within the AGM, partly by blocking further haematopoietic differentiation. In the embryonic AGM, therefore, BMP4 may have a similar effect on cell behaviour to that of TGFb on postnatal cells in the maintenance of a primitive, multipotent population that resides within the CD34 + /c-Kit low compartment.
This model for BMP function is supported by studies on the drosophila ovariole in which BMP signals produced from niche cells maintain self-renewing germline stem cells by blocking differentiation (Kai & Spradling, 2004; Song et al, 2004) . Short-range BMP-signalling induces elevated levels of a group of proteins in stem cells adjacent to cap cells at the niche interface. These proteins bind to the silencer element of a differentiation-promoting gene bag of marbles (bam) repressing its transcription and blocking differentiation to the next stage of germ cell development. As cells move away from the cap cells and beyond BMP signalling range, bam is expressed and the cells can differentiate. BMP also expands the BL-CFC haemangioblast population and consequently increases haematopoietic output in murine ES cells (Zafonte et al, 2007) .
Members of the Runx family of transcription factors have also been linked to the BMP pathway. Runx1 is transiently expressed in the floor of the dorsal aorta during the period of haematopoietic activity and is required for HSC generation (North et al, 1999) . Recently it has been demonstrated that the BMP4/Smad signalling pathway, the SCL/Tal1 transcription network and regulation of Runx1 activity are linked and determine HSC development (Pimanda et al, 2007) . Within the embryonic AGM, BMP-activated Smad-Runx complexes may regulate expression of target genes involved in lineage commitment and haematopoietic specification.
The development of more reliable and efficient culture systems for clinical applications requires a greater knowledge of how stem cells are regulated at the molecular level. The microenvironment that supports mammalian HSC generation in vivo contains a variety of factors that may work synergistically or antagonistically at different stages of HSC induction, maintenance and maturation. Within the embryonic context, we have placed BMP4 within this complex network at an early stage, possibly in the regulation of haemangioblast development, resulting in the production of a pool HSCs to seed the adult haematopoietic system. Further investigations will reveal how growth factors co-operate to regulate haematopoietic development from embryo to adult and so unravel the complicated pathway that leads from mesodermal cell to blood.
